| |||
SECURITIES AND EXCHANGE COMMISSION | |||
Washington, D.C. 20549 | |||
| |||
SCHEDULE 14A | |||
| |||
Proxy Statement Pursuant to Section 14(a) of | |||
| |||
Filed by Registrant x | |||
| |||
Filed by a Party other than the Registrant o | |||
| |||
Check the appropriate box: | |||
o | Preliminary Proxy Statement | ||
o | Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) | ||
o | Definitive Proxy Statement | ||
o | Definitive Additional Materials | ||
x | Soliciting Material Pursuant Section 240.14a-12 | ||
| |||
ADVANCED LIFE SCIENCES HOLDINGS, INC. | |||
(Exact name of Registrant as Specified In Its Charter) | |||
| |||
Payment of Filing Fee (Check the appropriate box): | |||
x | No fee required. | ||
o | Fee computed on table below per Exchange Act Rules 14a-6(i)(1) and 0-11. | ||
| (1) | Title of each class of securities to which transaction applies: | |
|
|
| |
| (2) | Aggregate number of securities to which transaction applies: | |
|
|
| |
| (3) | Per unit price or other underlying value of transaction computed pursuant to Exchange Act Rule 0-11 (set forth the amount on which the filing fee is calculated and state how it was determined): | |
|
|
| |
| (4) | Proposed maximum aggregate value of transaction: | |
|
|
| |
| (5) | Total fee paid: | |
|
|
| |
o | Fee paid previously with preliminary materials. | ||
o | Check box if any part of the fee is offset as provided by Exchange Act Rule 0-11(a)(2) and identify the filing for which the offsetting fee was paid previously. Identify the previous filing by registration statement number, or the Form or Schedule and the date of its filing. | ||
| (1) | Amount Previously Paid: | |
|
|
| |
| (2) | Form, Schedule or Registration Statement No.: | |
|
|
| |
| (3) | Filing Party: | |
|
|
| |
| (4) | Date Filed: | |
|
|
| |
On February 24, 2009, the Board of Directors of Advanced Life Sciences Holdings, Inc. sent the following letter to George P. Nottingham and Groundworks of Palm Beach County, Inc.:
[ADLS LETTERHEAD]
February 24, 2009
Mr. George P. Nottingham
Groundworks of Palm Beach County, Inc.
8140 93rd Lane South
Boynton Beach, FL 33472
Dear Mr. Nottingham:
On behalf of the Board of Directors of Advanced Life Sciences Holdings, Inc., thank you for your letter dated February 20, 2009, and for your interest in the Company. The Board will consider any thoughtful request made by its valued shareholders and will take your suggestions into consideration as the Company prepares to finalize its definitive proxy statement for mailing on or about February 27, 2009.
As you know, you are cordially invited to attend the annual meeting of stockholders of Advanced Life Sciences Holdings, Inc. to be held at 11:00 a.m. local time on Wednesday, April 1, 2009, at 1440 Davey Road, Woodridge, Illinois 60517. We hope you will consider attending and look forward to your continued interest in the Company.
| Sincerely, |
|
|
|
|
| /s/ Michael T. Flavin |
|
| Michael T. Flavin, Ph.D. |
|
| Chairman and Chief Executive Officer |
|
ADDITIONAL INFORMATION
The soliciting material presented herein is prepared by and on behalf of the Board of Directors of Advanced Life Sciences Holdings, Inc. (“ADLS”) in connection with proposals to be presented to shareholders at the upcoming annual meeting of shareholders of ADLS. Information regarding the shareholdings of management and the Board of Directors of ADLS can be found in the Preliminary Proxy Statement filed with the SEC on February 6, 2009 and in the company’s other filings with the Securities and Exchange Commission. Additional information will be contained in the definitive proxy statement to be filed by ADLS with the Securities and Exchange Commission prior to the annual meeting. A copy of the definitive proxy statement will be mailed to each shareholder of record prior to the annual meeting, and will be available for free at the SEC’s website, www.sec.gov, and may also be obtained free (when available) from the company.
SHAREHOLDERS SHOULD READ THE DEFINITIVE PROXY STATEMENT WHEN IT BECOMES AVAILABLE BECAUSE IT WILL CONTAIN IMPORTANT INFORMATION CONCERNING THE COMPANY’S PROPOSALS.